SCLT1

SCLT1 is a centriole distal appendage protein required for ciliogenesis (PMID:28486600, PMID:30425282). In mice, loss of Sclt1 reduces the number of cilia in kidney tubule epithelial cells and activates PKA, ERK, SMAD, and STAT3 signaling, producing cystic kidney disease; pharmacological inhibition of STAT3 with pyrimethamine reduces embryonic kidney cyst formation, placing SCLT1 upstream of STAT3 in this pathway (PMID:28486600). Consistent with its ciliary role, the protein localizes specifically to the distal appendage of the photoreceptor basal body (PMID:30425282). At the post-transcriptional level, the METTL1/WDR4 methyltransferase complex deposits N7-methylguanosine (m7G) marks on SCLT1 mRNA to stabilize the transcript, and this regulation promotes gefitinib resistance via NF-κB activation (PMID:40857569).

1. 2017 Medium

   Established that SCLT1 is functionally required for ciliogenesis and that its loss perturbs downstream signaling, defining a causal link between the distal appendage protein and cystic kidney disease.

   Evidence Sclt1 knockout mouse with cilia counting in kidney, pathway western blots, and pharmacological STAT3 rescue with pyrimethamine

   PMID:28486600

   Open questions at the time

   • Molecular mechanism by which SCLT1 loss activates PKA/ERK/SMAD/STAT3 is not resolved
   • Direct binding partners of SCLT1 at the distal appendage not identified
   • Single lab; human disease causation not tested in this study
2. 2018 Medium

   Pinpointed SCLT1 protein to the distal appendage of the photoreceptor basal body, corroborating its centriolar localization across tissues.

   Evidence Immunohistochemical localization in retinal photoreceptors

   PMID:30425282

   Open questions at the time

   • Single method (immunolocalization) without functional perturbation in photoreceptors
   • Does not define how SCLT1 is recruited to or anchored at the distal appendage
3. 2025 Medium

   Revealed a post-transcriptional control layer in which m7G methylation by METTL1/WDR4 stabilizes SCLT1 mRNA, connecting SCLT1 abundance to NF-κB-driven drug resistance.

   Evidence m7G MeRIP-seq with RNA-seq, METTL1/WDR4 knockdown/overexpression with catalytic-mutant controls and mRNA stability assays, NF-κB readouts in cell and animal models

   PMID:40857569

   Open questions at the time

   • How elevated SCLT1 protein mechanistically activates NF-κB is not defined
   • Relationship between the ciliary function of SCLT1 and gefitinib resistance is unclear
   • Single lab; reader effectors of the m7G mark on SCLT1 mRNA not identified

• The molecular mechanism connecting SCLT1's structural role at the distal appendage to the signaling pathways it influences (STAT3, NF-κB) remains undefined.
• No direct protein interaction partners of SCLT1 characterized in the corpus
• No structural model of SCLT1 within the distal appendage
• Mechanistic chain from cilia loss to specific downstream signaling not mapped